Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Sell
2,026
-85
-4% -$24K 0.08% 125
2026
Q1
$563K Sell
2,111
-50
-2% -$13.8K 0.09% 115
2025
Q4
$595K Sell
2,161
-43
-2% -$12.1K 0.08% 114
2025
Q3
$635K Sell
2,204
-50
-2% -$14.8K 0.09% 112
2025
Q2
$745K Buy
+2,254
New +$727K 0.12% 91
2024
Q4
Sell
-2,158
Closed -$748K 222
2024
Q3
$748K Sell
2,158
-24
-1% -$8.26K 0.13% 93
2024
Q2
$721K Buy
2,182
+159
+8% +$54.8K 0.14% 89
2024
Q1
$735K Buy
+2,023
New +$666K 0.13% 89

Other funds holding CI

CFO4Life Group's CI Position: Q2 2026 in Review

CFO4Life Group reduced its Cigna (CI) stake by 4% in Q2 2026, selling an estimated $24K and leaving 2,026 shares worth $559K. The position accounts for 0.08% of the portfolio, ranked #125.

CFO4Life Group first reported a position in CI in Q1 2024 and has held it in 8 quarters since. The position peaked at $748K in Q3 2024. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • CFO4Life Group held 2,026 shares of Cigna worth $559K as of Q2 2026.
  • CFO4Life Group sold 85 Cigna shares in Q2 2026, an estimated $24K.
  • Cigna made up 0.08% of CFO4Life Group's portfolio in Q2 2026, its #125 holding.
  • CFO4Life Group first reported a position in Cigna in Q1 2024 and has held it in 8 quarters since.
  • CFO4Life Group's Cigna position peaked at $748K in Q3 2024.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.